Abscopal Effect of Radiotherapy and Nivolumab in Relapsed Hodgkin Lymphoma After Anti-PD1 Therapy
Clinical trial NCT03480334 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03480334
- Sponsor
- University of Cologne
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-05
- Primary completion
- 2024-05-04
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.